Australia
University of Newcastle - Department of Respiratory Medicine
Pirfenidone, IDIOPATHIC PULMONARY FIBROSIS, IPF, pirfenidone solution for inhalation (AP01), ACTRN12618001838202, aerosol delivery, interstitial lung disease, forced vital capacity